UVA Health · New patients

The laboratory

Basic science that changes the operation

Disc degeneration, macrophage biology, nanomedicine, and gene therapy — an NIH-funded lab translating discoveries into the clinic since 2004.

University biomedical research laboratory

Dr. Li is an NIH-funded spine surgeon active in both laboratory and clinical research. He established an independent laboratory at the University of Virginia in 2004 and leads an internationally recognized program on disc degeneration and its treatment with stem cells, nanotechnology, and gene therapy.

By translating those discoveries into clinical care, he offers patients options that are current, evidence-based, and — whenever possible — less invasive than the default operation of a generation ago.

A stage-based approach to disc regeneration

In early disc degeneration, enough viable nucleus pulposus cells remain that minimally invasive non–cell-based therapies such as gene transfer or growth factor injection can be appropriate. In moderate degeneration, loss of those cells limits those approaches, and ex vivo cell-based strategies become more relevant. In advanced degeneration, when the disc is largely nonfunctional, replacement with a tissue-engineered or artificial construct is the honest next step.

Current directions

Targeted therapy for radiculopathy

A short peptide that binds a marker on activated macrophages around a disc herniation, linked to a nanoparticle with anti-inflammatory and antioxidative properties. The long-term aim is a peripheral-vein injection that reduces inflammation at the herniation site — work a nurse could one day administer.

Read more

Optimizing outcomes in lumbar fusion

Our recent study found that ALIF provides superior restoration of lower lumbar lordosis compared with TLIF, while significantly reducing adjacent segment disease and the need for revision surgery. These findings help guide surgical decision-making and support more durable spinal alignment following fusion procedures.

Read more

Coin test for cervical myelopathy

A complementary examination for upper-extremity function in cervical myelopathy, published as a practical addition to the standard neurologic exam.

Read more

Federal grants

Selected NIH awards as principal investigator.

  • 2025 – 2030NIH R01Targeting stage specific influxed monocytes to treat acute and chronic back pain
  • 2024 – 2026NIH R21A soft electronics-enabled smart microneedle patch for neck pain management
  • 2023 – 2025NIH R21Macrophage anchoring nanomedicine to replace steroids for intra-articular injection
  • 2022 – 2027NIH R01Deciphering macrophage function in disc herniation
  • 2021 – 2023NIH R21An ex vivo system to model the inflammatory microenvironment of human disc herniation
  • 2018 – 2021NIH R21Disc-on-chip: microfluidic nutrition and biomechanical loading integrated mouse disc culture system
  • 2013 – 2020NIH R01Systemic application for injury site specific delivery via neutrophils to treat acute back pain
  • 2011 – 2015NIH R21Treatment of disc degeneration by nano-fullerenes
  • 2006 – 2010NIH R03GDF-5 regulation in intervertebral disc degeneration

Society and foundation support

  • 2025–2027 CHRB, co-PI (Li / Xu / Jin)
  • 2022–2024 Coulter Foundation, co-PI (Li / Xu / Jin)
  • 2021–2022 North American Spine Society research grant
  • 2021–2022 4-VA Collaborative Grant
  • 2018–2020 Commonwealth Health Research Board, Virginia
  • 2013–2015 & 2011–2012 North American Spine Society research grants (PI)
  • 2008–2010 Scoliosis Research Society research grant (PI)
  • 2007–2008 Cervical Spine Research Society seed grant (PI)
  • 2004–2007 Arthritis Foundation postdoctoral fellowship (PI)

Selected publications

Google Scholar
  • 2023Xiao L, et al. Transient depletion of macrophages alters local inflammatory response at the site of disc herniation in a transgenic mouse model. Osteoarthritis and Cartilage.
  • 2021Jin L, Xiao L, Ding M, Pan A, Balian G, Sung SS, Li X. Heterogeneous macrophages contribute to the pathology of disc herniation induced radiculopathy. Spine J.
  • 2019Li X, Lenke L, Jin L, Tuchman A, Tan L, Lehman R, Cerpa M. Surgeon specific risk stratification model for early complications following complex adult spinal deformity surgery. Spine Deformity.
  • 2018Xiao L, et al. Hydroxylated fullerene: a stellar nanomedicine to treat lumbar radiculopathy. ACS Biomaterials Science & Engineering.
  • 2013Liu Q, Jin L, Shen FH, Balian G, Li X. Fullerol nanoparticles suppress inflammatory response and adipogenesis of vertebral bone marrow stromal cells. Spine J.
  • 2008Cui M, et al. Mouse growth and differentiation factor-5 protein and DNA therapy potentiates intervertebral disc cell aggregation. Spine Journal. Outstanding Paper Award.

Investigators

  • Li Jin, PhD

    Professor of Research

  • Li Xiao, PhD

    Assistant Professor of Research

  • Yuan Xing, PhD

    Research Scientist

In the press

Appointments

Ready to take the next step toward recovery?

New patients are welcome. Call the spine clinic or send a note — the team will help you find the right visit.